AKEBIA THERAPEUTICS, INC. (AKBA) Gross profit 2018–2025
AKEBIA THERAPEUTICS, INC. (AKBA) annual gross profit history from SEC filings — each fiscal year as reported.
$196.7MFY2025 · since FY2018: $200.0M → $196.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $196.7M | +102.8% |
| FY2024 | $97.0M | -19.5% |
| FY2023 | $120.5M | -41.8% |
| FY2022 | $206.9M | +239.3% |
| FY2021 | $61.0M | +3426.7% |
| FY2020 | -$1.8M | -101.0% |
| FY2019 | $189.7M | -5.2% |
| FY2018 | $200.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AKBA financial trends
AKBA RevenueAKBA Net incomeAKBA Net marginAKBA Gross marginAKBA Operating incomeAKBA Operating marginAKBA Operating cash flowAKBA Free cash flowAKBA Capital expendituresAKBA Return on equityAKBA Stock buybacksAKBA Dividends paidAKBA Total assetsAKBA Total liabilitiesAKBA Shareholders’ equityAKBA overview →